Press release Medios AG Annual General Meeting 2025: Shareholders approve all proposed resolutions Berlin, May 27, 2025 – The shareholders of Medios, a leading provider of Specialty Pharma in Europe, today approved all resolutions proposed by the Executive Board and Supervisory Board at the 2025 Annual General Meeting with a large majority. In to [ … ]

Press release Medios starts 2025 financial year successfully with significant increase in earnings Revenue up 6.2% to €484.7 million in the first quarter Significantly higher increase in EBITDA pre1 of 52.9% to €23.1 million with margin improvement to 4.8% Earnings per share increased to €0.25 from €0.17 in Q1 2024 2025 forecast confirmed: Fur [ … ]

Press release Medios repositions itself for the next phase of its corporate development The company's founding team is leaving Medios at its own request Matthias Gärtner hands over the CEO position to a successor after a transition period Mi-Young Miehler (COO) will leave the company on 30 June 2025 Berlin, May 12, 2025 - Medios AG ("Medios"),  [ … ]

Press release Medios expects further growth in revenue and earnings after record year 2024 Consolidated revenue increases to €1.9 billion (+5.5%) EBITDA pre1 with disproportionate growth of 30.5% and significantly improved EBITDA pre1 margin of 4.2% (previous year: 3.4%) Strong operating cash flow Outlook for 2025: revenue growth to around €2. [ … ]

Press release Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025 Preliminary figures 2024 Revenue increases to around €1.9 billion (+5.5%) Disproportionate increase of EBITDA pre1 to around €79 million (+31%); EBITDA pre1 margin significantly improved to around 4.2% (previous year: 3.4 [ … ]